X hits on this document





17 / 49


treatments. G. O. Gabbard (Ed.); Arlington, VA, US: American Psychiatric Publishing, Inc., pp. 239-262.

Cognitive-behavioral therapy (CBT) has received an enormous amount of research attention and has been identified as an empirically supported therapy for numerous psychiatric disorders and medical conditions with psychological components. It is one of the most commonly used psychotherapeutic treatments in adults. Surveys indicate that CBT is expected to remain among the foremost foci of psychotherapy training in the coming years, and its importance in the field of psychotherapy is likely to increase. In this chapter we review applications of individual CBT to a variety of psychiatric disorders and review their efficacy and indications. We also discuss the limitations of and knowledge gaps within the current empirical literature, and present suggestions for future research and applications.  

 Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: A meta-regression of factors that may predict outcome.

Haby, M. M., Donnelly, M., Corry, J. & Vos, T. (2006). Australian and New Zealand Journal of Psychiatry, 40(1), 9-19.

Objective: To determine which factors impact on the efficacy of cognitive behavioural therapy (CBT) for depression and anxiety. Factors considered include those related to clinical practice: disorder, treatment type, duration and intensity of treatment, mode of therapy, type and training of therapist and severity of patients. Factors related to the conduct of the trial were also considered, including: year of study, country of study, type of control group, language, number of patients and percentage of dropouts from the trial. Method: We used the technique of meta-analysis to determine an overall effect size (standardized mean difference calculated using Hedges' g) and meta-regression to determine the factors that impact on this effect size. We included randomized controlled trials with a wait list, pill placebo or attention/psychological placebo control group. Study participants had to be 18 years or older and all have diagnosed depression, panic disorder (with or without agoraphobia) or generalized anxiety disorder (GAD). Outcomes of interest included symptom, functioning and health-related quality of life measures, reported as continuous variables at post-treatment. Results: Cognitive behavioural therapy for depression, panic disorder and GAD had an effect size of 0.68 (95% 01 = 0.51-0.84, n = 33 studies, 52 comparisons). The heterogeneity in the effect sizes was fully explained by treatment, duration of therapy, inclusion of severe patients in the trial, year of study, country of study, control group, language and number of dropouts from the control group. Disorder was not a significant predictor of the effect size. Conclusions: Cognitive behavioural therapy is significantly less effective for severe patients and trials that compared CBT to a wait-list control group found significantly larger effect sizes than those comparing CBT to an attention placebo, but not to a pill placebo. Further research is needed to determine whether CBT is effective when provided by others than psychologists and whether it is effective for non-English-speaking patient groups.  


The Big Question: Does cognitive therapy work – and should the NHS provide more of it for depression?

By Jeremy Laurance, Health Editor

Why are we asking this now?

Document info
Document views71
Page views71
Page last viewedMon Oct 24 16:21:41 UTC 2016